Price Michael F Lowers stake in Dolby Laboratories (DLB)

Dolby Laboratories (DLB) : Price Michael F reduced its stake in Dolby Laboratories by 8.28% during the most recent quarter end. The investment management company now holds a total of 930,955 shares of Dolby Laboratories which is valued at $44,034,172 after selling 84,020 shares in Dolby Laboratories , the firm said in a disclosure report filed with the SEC on Nov 14, 2016.Dolby Laboratories makes up approximately 5.87% of Price Michael F’s portfolio.

Other Hedge Funds, Including , D. E. Shaw boosted its stake in DLB in the latest quarter, The investment management firm added 23,356 additional shares and now holds a total of 206,746 shares of Dolby Laboratories which is valued at $9,797,693. Dolby Laboratories makes up approx 0.02% of D. E. Shaw’s portfolio.Tower Research Capital (trc) reduced its stake in DLB by selling 708 shares or 70.73% in the most recent quarter. The Hedge Fund company now holds 293 shares of DLB which is valued at $13,771. Victory Capital Management Inc added DLB to its portfolio by purchasing 14,515 company shares during the most recent quarter which is valued at $678,576.Public Employees Retirement Association Of Colorado boosted its stake in DLB in the latest quarter, The investment management firm added 7 additional shares and now holds a total of 10,139 shares of Dolby Laboratories which is valued at $473,289.Next Financial Group Inc boosted its stake in DLB in the latest quarter, The investment management firm added 50 additional shares and now holds a total of 209 shares of Dolby Laboratories which is valued at $9,756.

Dolby Laboratories closed down -0.21 points or -0.44% at $47 with 6,49,640 shares getting traded on Monday. Post opening the session at $47.14, the shares hit an intraday low of $46.92 and an intraday high of $47.24 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Dolby Laboratories reported $0.37 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Oct 26, 2016. Analyst had a consensus of $0.35. The company had revenue of $233.00 million for the quarter, compared to analysts expectations of $226.45 million. The company’s revenue was up .1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.43 EPS.

Many Wall Street Analysts have commented on Dolby Laboratories. Dolby Laboratories was Resumed by JP Morgan to “Neutral” on Oct 4, 2016.

Dolby Laboratories Inc. (Dolby Laboratories) creates audio imaging and communication technologies that transform entertainment and communications at the cinema at home at work and on mobile devices. The Company licenses its audio technologies and also develops technologies aimed at enhancing voice conferencing communications and imaging. Additionally the Company provides products and services that enable entertainment content creators and distributors to produce encode transmit and playback content for consumer experiences. The Company designs and manufactures audio and imaging products for the film production cinema and television broadcast industries. Distributed in approximately 80 countries these products are used in content creation distribution and playback to enhance image and sound quality and improve transmission and playback.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Dolby Laboratories - Is it time to Sell?

Top Brokerage Firms are advising their investors on Dolby Laboratories. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.